Altimmune, Inc.ALTNASDAQ
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-16.9%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
-16.9%/yr
vs -5.0%/yr prior
Acceleration
-11.9pp
Decelerating
Percentile
P50
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20257.33%
2024-7.48%
2023-4.41%
202212.75%
2021-97.96%
2020-139.01%
201947.61%
201815.63%
2017-123.95%
20165734.14%